Clinical Trial Update: Minocycline as add-on to Interferon Beta-1a [IFN Beta-1a] (Rebif®) in Relapsing-Remitting Multiple Sclerosis [RRMS] [Phase 2]

View source ↗

Summary

A Phase 2 study tested adding minocycline to Interferon beta-1a (Rebif) in relapsing-remitting multiple sclerosis; the trial was terminated with results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• Minocycline (minocycline)
• Rebif (interferon beta-1a)

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Multiple Sclerosis, Relapsing-Remitting | Phase 2 | Status: TERMINATED | Results posted: 2012-09-05